Tag: Alternative Brands
-
Category H introduction …. the end of branded generics in the UK?
by
Category H introduction has been announced although detail is lacking. It will undoubtedly affect branded generics and this article gives an outline as to how and why.
-
Re-positioning an established “Alternative Brand” (branded-generic)
by
Challenge: In the UK, NHS advice is to prescribe some products (including drug / device combinations) by brand name when generics exist, so that patient continuity is ensured. With the launch of a new competitor branded-generic, this company’s alternative brand’s positioning was no longer compelling or even valid. We supported the UK affiliate to reposition…
-
Established molecules – more than “just” generics?
by
A frequent response to hearing the words “established molecules” is “so you mean generics, right?” Well yes, and no! There is more to it than “just generics” and in fact this is an exciting and profitable area of pharma and one we love to work on here at Hawk Pharma Consulting.
